½ÃÀ庸°í¼­
»óǰÄÚµå
1622868

¼¼°èÀÇ ³×ºí¶óÀÌÀú ±â±â ½ÃÀå : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2031³â)

Nebulizer Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Persistence Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 244 Pages | ¹è¼Û¾È³» : 2-5ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è ³×ºí¶óÀÌÀú ±â±â ½ÃÀå ±Ô¸ð´Â 2024³â 11¾ï 2,080¸¸ ´Þ·¯¿¡ À̸£°í, 2024-2031³âÀÇ ¿¹Ãø ±â°£ µ¿¾È 8.5%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î È®´ëµÇ¾î 2031³â¿¡´Â 19¾ï 7,800¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

³×ºí¶óÀÌÀú ±â±â´Â ÁַΠõ½Ä, ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), ³¶Æ÷¼º¼¶À¯Áõ°ú °°Àº È£Èí±â ÁúȯÀ» Ä¡·áÇϱâ À§ÇØ Æó¿¡ ÈíÀÔÇÏ´Â ¹Ì½ºÆ® ÇüÅ·Π¾à¹°À» Åõ¿©ÇÏ´Â µ¥ »ç¿ëµÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ³×ºí¶óÀÌÀú ±â±â¿¡´Â Á¦Æ® ³×ºí¶óÀÌÀú ±â±â, ¸Þ½¬ ³×ºí¶óÀÌÀú ±â±â, ÃÊÀ½ÆÄ ³×ºí¶óÀÌÀú ±â±â µîÀÌ ÀÖÀ¸¸ç, ÀçÅÃÄ¡·á ¹× º´¿ø ȯ°æ¿¡¼­ ¸ðµÎ »ç¿ëµË´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â È£Èí±â ÁúȯÀÇ À¯º´·ü Áõ°¡, ³ëÀÎ Àα¸ Áõ°¡, È£Èí±â °Ç°­¿¡ ´ëÇÑ ÀÎ½Ä Áõ°¡ µîÀ» µé ¼ö ÀÖ½À´Ï´Ù.

¼¼°è ³×ºí¶óÀÌÀú ±â±â ½ÃÀåÀº Àü ¼¼°è õ½Ä ¹× COPD À¯º´·ü Áõ°¡ µî ¿©·¯ ¿äÀÎÀ¸·Î ÀÎÇØ Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. È£Èí±â Áúȯ¿¡ Ãë¾àÇÑ °í·ÉÈ­ Àα¸ Áõ°¡´Â ³×ºí¶óÀÌÀú ±â±â ¼ö¿ä¸¦ ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÈÞ´ë¿ë ¹× »ç¿ëÀÚ Ä£È­Àû ÀÎ ÀåÄ¡¿Í °°Àº ³×ºí¶óÀÌÀú ±â±â ±â¼úÀÇ ¹ßÀü°ú °Ç°­ °ü¸®¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀçÅÃÄ¡·á ¼Ö·ç¼ÇÀ¸·ÎÀÇ Àüȯ°ú ºñħ½ÀÀû Ä¡·á¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁü¿¡ µû¶ó ÀçÅà ȯ°æ¿¡¼­ ³×ºí¶óÀÌÀú ±â±âÀÇ Ã¤ÅÃÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

³×ºí¶óÀÌÀú ±â±â ½ÃÀåÀº È£Èí±â °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁö°í ȨÄÉ¾î ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó Å« ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¼ÒÇü ÈÞ´ë¿ë ¹èÅ͸®½Ä ³×ºí¶óÀÌÀú ±â±âÀÇ °³¹ß°ú °°Àº ±â¼ú Çõ½ÅÀº »õ·Î¿î ¼ºÀå ±âȸ¸¦ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ȯ°æÀû ¿äÀΰú ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È­·Î ÀÎÇØ È£Èí±â ÁúȯÀÌ Áõ°¡Çϰí ÀÖ´Â ½ÅÈï ½ÃÀå¿¡µµ Å« ÀáÀç·ÂÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, õ½Ä ¹× COPD¿¡ ´ëÇÑ º´¿ë¿ä¹ý äÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ³×ºí¶óÀÌÀú ±â±â Á¦Á¶¾÷ü´Â ƯÁ¤ Ä¡·á¹ý¿¡ ¸Â´Â ±â±â¸¦ °³¹ßÇÒ ¼ö ÀÖ´Â ±âȸ¸¦ ¾ò°Ô µÇ¾ú½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ¼¼°è ³×ºí¶óÀÌÀú ±â±â ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, Á¦Ç° À¯Çüº°/ÃÖÁ¾ »ç¿ëÀÚº°/¿ëµµº°/Áö¿ªº° µ¿Çâ, ½ÃÀå ÁøÃâ±â¾÷ ÇÁ·ÎÆÄÀÏ µîÀÇ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå ¼­·Ð

Á¦3Àå ½ÃÀå ½ÃÁ¡

  • °Å½ÃÀû ¿äÀÎ
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • µ¿Çâ
  • ±âȸ
  • ±¹°¡º° Àü¸Á(ºÏ¹Ì)
  • ±¹°¡º° Àü¸Á(À¯·´ ¹× ¾Æ½Ã¾ÆÅÂÆò¾ç)
  • ¹Ì±¹ÀÇ COPD À¯º´·ü
  • ¹Ì±¹ÀÇ Ãµ½Ä À¯º´·ü
  • ¼±È£¿Í ÀλçÀÌÆ®
  • Á¦Ç° ½ÃÀå ½Ã³ª¸®¿À
  • Á¦Ç° À¯Çü ÁøÈ­
  • ÀÌÀÍ·ü°ú ¸ÅÃ⠺м®
  • Á¦Á¶¾÷ü
  • õ½Ä°ú COPD¿¡ »ç¿ëµÇ´Â ¾àÁ¦
  • »óȯ(ºÏ¹Ì)
  • ·»Å» Á¦Ç° ½Ã³ª¸®¿À(ºÏ¹Ì)
  • º¸Çè(ºÏ¹Ì)
  • PorterÀÇ Five Forces ºÐ¼®
  • ÁÖ¿ä ±ÔÁ¦

Á¦4Àå ºÏ¹ÌÀÇ ³×ºæ¶óÀÌÀú Àåºñ ½ÃÀå ºÐ¼®(2019³â-2023³â) ¹× ¿¹Ãø(2024³â-2031³â)

  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, 2019³â-2023³â, ±¹°¡º°
  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ¿¹Ãø, 2024³â-2031³â, ±¹°¡º°
  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, 2019³â-2023³â, Á¦Ç° À¯Çüº°
  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ¿¹Ãø, 2024³â-2031³â, Á¦Ç° À¯Çüº°
  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, 2019³â-2023³â, ¿ëµµº°
  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ¿¹Ãø, 2024³â-2031³â, ¿ëµµº°
  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, 2019³â-2023³â, ÃÖÁ¾»ç¿ëÀÚº°
  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ¿¹Ãø, 2024³â-2031³â, ÃÖÁ¾»ç¿ëÀÚº°
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®
  • ÁÖ¿ä ´ëÇ¥ÀûÀÎ ½ÃÀå ÁøÃâ±â¾÷
  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷ ½ÃÀå ÀÔÁö(°­µµ ¸Ê)

Á¦5Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ ³×ºæ¶óÀÌÀú Àåºñ ½ÃÀå ºÐ¼®(2019³â-2023³â) ¹× ¿¹Ãø(2024³â-2031³â)

Á¦6Àå ¼­À¯·´ÀÇ ³×ºæ¶óÀÌÀú Àåºñ ½ÃÀå ºÐ¼®(2019³â-2023³â) ¹× ¿¹Ãø(2024³â-2031³â)

Á¦7Àå µ¿À¯·´ÀÇ ³×ºæ¶óÀÌÀú Àåºñ ½ÃÀå ºÐ¼®(2019³â-2023³â) ¹× ¿¹Ãø(2024³â-2031³â)

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç(ÀϺ» Á¦¿Ü)ÀÇ ³×ºæ¶óÀÌÀú Àåºñ ½ÃÀå ºÐ¼®(2019³â-2023³â) ¹× ¿¹Ãø(2024³â-2031³â)

Á¦9Àå ÀϺ»ÀÇ ³×ºæ¶óÀÌÀú Àåºñ ½ÃÀå ºÐ¼®(2019³â-2023³â) ¹× ¿¹Ãø(2024³â-2031³â)

Á¦10Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ³×ºæ¶óÀÌÀú Àåºñ ½ÃÀå ºÐ¼®(2019³â-2023³â) ¹× ¿¹Ãø(2024³â-2031³â)

Á¦11Àå ¿¹Ãø ¿äÀÎ : °ü·Ã¼º°ú ¿µÇâ

Á¦12Àå ¿¹ÃøÀÇ ÀüÁ¦Á¶°Ç

Á¦13Àå °æÀï ±¸µµ

  • °æÀï ´ë½Ãº¸µå
  • ±â¾÷ °³¿ä(»ó¼¼ - °³¿ä, À繫, Àü·«, ÃÖ±Ù µ¿Çâ)
    • Agilent Technologies, Inc.
    • Allied Healthcare Products, Inc.
    • CareFusion Corporation(sub. Becton, Dickinson and Company)
    • Covidien plc(sub. Medtronic)
    • GE Healthcare
    • GF Health Products Inc.
    • Omron Healthcare, Inc.
    • PARI GmbH
    • Koninklijke Philips N.V.

Á¦14Àå ¼¼°èÀÇ ³×ºæ¶óÀÌÀú Àåºñ ½ÃÀå ºÐ¼®(2019³â-2023³â) ¹× ¿¹Ãø(2024³â-2031³â), Áö¿ªº°

  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, 2019³â-2023³â, Áö¿ªº°
  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ¿¹Ãø, 2024³â-2031³â, Áö¿ªº°
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, Áö¿ªº°

Á¦15Àå ¼¼°èÀÇ ³×ºæ¶óÀÌÀú Àåºñ ½ÃÀå ºÐ¼®(2019³â-2023³â) ¹× ¿¹Ãø(2024³â-2031³â), Á¦Ç° À¯Çüº°

  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, 2019³â-2023³â, Á¦Ç° À¯Çüº°
  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ¿¹Ãø, 2024³â-2031³â, Á¦Ç° À¯Çüº°
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, Á¦Ç° À¯Çüº°

Á¦16Àå ¼¼°èÀÇ ³×ºæ¶óÀÌÀú Àåºñ ½ÃÀå ºÐ¼®(2019³â-2023³â) ¹× ¿¹Ãø(2024³â-2031³â), ¿ëµµº°

  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, 2019³â-2023³â, ¿ëµµº°
  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ¿¹Ãø, 2024³â-2031³â, ¿ëµµº°
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, ¿ëµµº°

Á¦17Àå ³×ºæ¶óÀÌÀú Àåºñ ½ÃÀå ºÐ¼®(2019³â-2023³â) ¹× ¿¹Ãø(2024³â-2031³â), ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ºÐ¼®, 2019³â-2023³â, ÃÖÁ¾»ç¿ëÀÚº°
  • ½ÃÀå ±Ô¸ð(100¸¸ ´Þ·¯) ¿¹Ãø, 2024³â-2031³â, ÃÖÁ¾»ç¿ëÀÚº°
  • ½ÃÀåÀÇ ¸Å·Â ºÐ¼®, ÃÖÁ¾»ç¿ëÀÚº°

Á¦18Àå ¼¼°èÀÇ(2019³â-2023³â) ¹× ¿¹Ãø(2024³â-2031³â)

Á¦19Àå Á¶»ç ¹æ¹ý

LSH 25.01.10

Persistence Market Research recently unveiled an in-depth report on the global Nebulizer Devices Market, analyzing key market dynamics, including drivers, trends, opportunities, and challenges. This comprehensive research provides exclusive data and projections for the nebulizer devices market's growth trajectory from 2024 to 2031.

Key Insights:

  • Nebulizer Devices Market Size (2024E): US$ 1120.8 Million
  • Projected Market Value (2031F): US$ 1978 Million
  • Global Market Growth Rate (CAGR 2024 to 2031): 8.5%

Nebulizer Devices Market Overview:

Nebulizers are medical devices used to administer medication in the form of a mist inhaled into the lungs, primarily for the treatment of respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Nebulizer devices include jet nebulizers, mesh nebulizers, and ultrasonic nebulizers, with applications across both homecare and hospital settings. Key drivers of market growth include the increasing prevalence of respiratory diseases, the rising geriatric population, and the growing awareness about respiratory health.

Market Growth Drivers:

The global nebulizer devices market is experiencing significant growth due to several factors, including the rising incidence of asthma and COPD worldwide. The growing aging population, which is more susceptible to respiratory disorders, further fuels the demand for nebulizer devices. Additionally, advancements in nebulizer technology, such as portable and user-friendly devices, along with increasing healthcare awareness, are contributing to the growth of the market. The shift towards home healthcare solutions and the rising preference for non-invasive treatments also support the adoption of nebulizers in home settings.

Market Restraints:

Despite positive growth prospects, the nebulizer devices market faces certain challenges. One of the key barriers is the relatively high cost of nebulizers, which may limit their affordability, particularly in developing countries. Moreover, the lack of awareness in some regions about the benefits of nebulizer treatments can also hinder market adoption. Regulatory challenges, including lengthy approval processes for new devices and the need for consistent product standards, may slow down the introduction of new, innovative devices. Additionally, the maintenance and cleaning requirements of nebulizers could be a deterrent for some patients, especially in homecare settings.

Market Opportunities:

The nebulizer devices market offers significant opportunities driven by the rising awareness of respiratory health and the growing demand for homecare solutions. Technological innovations, such as the development of compact, portable, and battery-operated nebulizers, present new growth opportunities. There is also considerable potential in emerging markets, where respiratory diseases are on the rise due to environmental factors and lifestyle changes. Furthermore, the increasing adoption of combination therapies for asthma and COPD provides opportunities for nebulizer manufacturers to develop devices tailored to specific treatments.

Key Questions Addressed:

  • What are the main factors driving the global growth of the nebulizer devices market?
  • Which product types and applications are witnessing the highest adoption in the nebulizer devices market?
  • How are technological advancements shaping the competitive landscape of the nebulizer devices market?
  • Who are the leading players in the nebulizer devices market, and what strategies are they employing to maintain leadership?
  • What are the emerging trends and future prospects for the global nebulizer devices market?

Competitive Intelligence & Strategic Insights:

Major players in the global nebulizer devices market, including Philips Healthcare, Omron Healthcare, and PARI GmbH, focus on product innovation, strategic partnerships, and expanding their product portfolios to strengthen their market position. These companies invest in research and development to create more efficient, user-friendly nebulizer devices with enhanced features. Collaborations with healthcare providers, pharmaceutical companies, and homecare organizations are key strategies to expand market reach. Furthermore, raising consumer awareness through educational campaigns about the benefits of nebulizer therapy is crucial for improving market penetration and driving long-term growth.

Key Companies Profiled:

  • Agilent Technologies, Inc.
  • Allied Healthcare Products, Inc.
  • CareFusion Corporation (sub. Becton, Dickinson and Company)
  • Covidien plc (sub. Medtronic)
  • GE Healthcare
  • GF Health Products Inc.
  • Omron Healthcare, Inc.
  • PARI GmbH
  • Koninklijke Philips N.V.

Nebulizer Devices Market: Segmentation

By Product Type

  • Compressed Jet Nebulizer
  • Breath Actuated Pneumatic Nebulizer
  • Vented Actuated Pneumatic Nebulizer
  • Ultrasound Nebulizer
  • Mesh Nebulizer

By End User

Homecare Settings

  • Out Patient Settings
  • Others
  • Hospitals
  • Clinics
  • Long Term Centers

By Application

  • COPD
  • Cystic Fibrosis
  • Asthma

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Market Overview
  • 1.2. Market Analysis
  • 1.3. PMR Analysis and Recommendations
  • 1.4. Wheel of Fortune

2. Market Introduction

  • 2.1. Market Definition
  • 2.2. Market Taxonomy
  • 2.3. Nebulizer Devices Market Overview

3. Market View Point

  • 3.1. Macro factors
  • 3.2. Drivers
  • 3.3. Restraints
  • 3.4. Trends
  • 3.5. Opportunities
  • 3.6. Outlook by Country (North America)
  • 3.7. Outlook by Country (Europe & Asia-Pacific)
  • 3.8. COPD Prevalence in U.S
  • 3.9. Asthma Prevalence in U.S
  • 3.10. Preferences and Insights
  • 3.11. Product Market Scenario
  • 3.12. Product Type Evolution
  • 3.13. Profit Margin and Revenue Analysis
  • 3.14. Manufacturer
  • 3.15. Drug Used for Asthma & COPD
  • 3.16. Reimbursement (North America)
  • 3.17. Rental Product Scenarios (North America)
  • 3.18. Insurances (North America)
  • 3.19. Porter's Five Forces Analysis
  • 3.20. Key Regulation

4. North America Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 4.1. Introduction
  • 4.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 4.2.1. U.S.
    • 4.2.2. Canada
  • 4.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 4.3.1. U.S.
    • 4.3.2. Canada
  • 4.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 4.4.1. Compressed Jet Nebulizer
      • 4.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 4.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 4.4.2. Ultrasound Nebulizer
    • 4.4.3. Mesh Nebulizer
  • 4.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 4.5.1. Compressed Jet Nebulizer
      • 4.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 4.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 4.5.2. Ultrasound Nebulizer
    • 4.5.3. Mesh Nebulizer
  • 4.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 4.6.1. COPD
    • 4.6.2. Cystic Fibrosis
    • 4.6.3. Asthma
    • 4.6.4. Others
  • 4.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 4.7.1. COPD
    • 4.7.2. Cystic Fibrosis
    • 4.7.3. Asthma
    • 4.7.4. Others
  • 4.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 4.8.1. Homecare Setting
    • 4.8.2. Out Patient Settings
    • 4.8.3. Others
      • 4.8.3.1. Hospitals
      • 4.8.3.2. Clinics
      • 4.8.3.3. Long Term Centers
  • 4.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 4.9.1. Homecare Setting
    • 4.9.2. Out Patient Settings
    • 4.9.3. Others
      • 4.9.3.1. Hospitals
      • 4.9.3.2. Clinics
      • 4.9.3.3. Long Term Centers
  • 4.10. Market Attractiveness Analysis
    • 4.10.1. By Country
    • 4.10.2. By Product Type
    • 4.10.3. By Application
    • 4.10.4. By End User
  • 4.11. Key Representative Market Participants
  • 4.12. Key Participants Market Presence (Intensity Map)

5. Latin America Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 5.1. Introduction
  • 5.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 5.2.1. Brazil
    • 5.2.2. Mexico
    • 5.2.3. Rest of Latin America
  • 5.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 5.3.1. Brazil
    • 5.3.2. Mexico
    • 5.3.3. Rest of Latin America
  • 5.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 5.4.1. Compressed Jet Nebulizer
      • 5.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 5.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 5.4.2. Ultrasound Nebulizer
    • 5.4.3. Mesh Nebulizer
  • 5.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 5.5.1. Compressed Jet Nebulizer
      • 5.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 5.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 5.5.2. Ultrasound Nebulizer
    • 5.5.3. Mesh Nebulizer
  • 5.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 5.6.1. COPD
    • 5.6.2. Cystic Fibrosis
    • 5.6.3. Asthma
    • 5.6.4. Others
  • 5.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 5.7.1. COPD
    • 5.7.2. Cystic Fibrosis
    • 5.7.3. Asthma
    • 5.7.4. Others
  • 5.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 5.8.1. Homecare Setting
    • 5.8.2. Out Patient Settings
    • 5.8.3. Others
      • 5.8.3.1. Hospitals
      • 5.8.3.2. Clinics
      • 5.8.3.3. Long Term Centers
  • 5.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 5.9.1. Homecare Setting
    • 5.9.2. Out Patient Settings
    • 5.9.3. Others
      • 5.9.3.1. Hospitals
      • 5.9.3.2. Clinics
      • 5.9.3.3. Long Term Centers
  • 5.10. Market Attractiveness Analysis
    • 5.10.1. By Country
    • 5.10.2. By Product Type
    • 5.10.3. By Application
    • 5.10.4. By End User
  • 5.11. Key Representative Market Participants
  • 5.12. Key Participants Market Presence (Intensity Map)

6. Western Europe Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 6.1. Introduction
  • 6.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 6.2.1. Germany
    • 6.2.2. U.K
    • 6.2.3. France
    • 6.2.4. Spain
    • 6.2.5. Italy
    • 6.2.6. Nordic Countries
    • 6.2.7. Rest of Western Europe
  • 6.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 6.3.1. Germany
    • 6.3.2. U.K
    • 6.3.3. France
    • 6.3.4. Spain
    • 6.3.5. Italy
    • 6.3.6. Nordic Countries
    • 6.3.7. Rest of Western Europe
  • 6.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 6.4.1. Compressed Jet Nebulizer
      • 6.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 6.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 6.4.2. Ultrasound Nebulizer
    • 6.4.3. Mesh Nebulizer
  • 6.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 6.5.1. Compressed Jet Nebulizer
      • 6.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 6.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 6.5.2. Ultrasound Nebulizer
    • 6.5.3. Mesh Nebulizer
  • 6.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 6.6.1. COPD
    • 6.6.2. Cystic Fibrosis
    • 6.6.3. Asthma
    • 6.6.4. Others
  • 6.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 6.7.1. COPD
    • 6.7.2. Cystic Fibrosis
    • 6.7.3. Asthma
    • 6.7.4. Others
  • 6.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 6.8.1. Homecare Setting
    • 6.8.2. Out Patient Settings
    • 6.8.3. Others
      • 6.8.3.1. Hospitals
      • 6.8.3.2. Clinics
      • 6.8.3.3. Long Term Centers
  • 6.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 6.9.1. Homecare Setting
    • 6.9.2. Out Patient Settings
    • 6.9.3. Others
      • 6.9.3.1. Hospitals
      • 6.9.3.2. Clinics
      • 6.9.3.3. Long Term Centers
  • 6.10. Market Attractiveness Analysis
    • 6.10.1. By Country
    • 6.10.2. By Product Type
    • 6.10.3. By Application
    • 6.10.4. By End User
  • 6.11. Key Representative Market Participants
  • 6.12. Key Participants Market Presence (Intensity Map)

7. Eastern Europe Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 7.1. Introduction
  • 7.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 7.2.1. Russia
    • 7.2.2. Poland
    • 7.2.3. Rest of Eastern Europe
  • 7.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 7.3.1. Russia
    • 7.3.2. Poland
    • 7.3.3. Rest of Eastern Europe
  • 7.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 7.4.1. Compressed Jet Nebulizer
      • 7.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 7.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 7.4.2. Ultrasound Nebulizer
    • 7.4.3. Mesh Nebulizer
  • 7.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 7.5.1. Compressed Jet Nebulizer
      • 7.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 7.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 7.5.2. Ultrasound Nebulizer
    • 7.5.3. Mesh Nebulizer
  • 7.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 7.6.1. COPD
    • 7.6.2. Cystic Fibrosis
    • 7.6.3. Asthma
    • 7.6.4. Others
  • 7.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 7.7.1. COPD
    • 7.7.2. Cystic Fibrosis
    • 7.7.3. Asthma
    • 7.7.4. Others
  • 7.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 7.8.1. Homecare Setting
    • 7.8.2. Out Patient Settings
    • 7.8.3. Others
      • 7.8.3.1. Hospitals
      • 7.8.3.2. Clinics
      • 7.8.3.3. Long Term Centers
  • 7.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 7.9.1. Homecare Setting
    • 7.9.2. Out Patient Settings
    • 7.9.3. Others
      • 7.9.3.1. Hospitals
      • 7.9.3.2. Clinics
      • 7.9.3.3. Long Term Centers
  • 7.10. Market Attractiveness Analysis
    • 7.10.1. By Country
    • 7.10.2. By Product Type
    • 7.10.3. By Application
    • 7.10.4. By End User
  • 7.11. Key Representative Market Participants
  • 7.12. Key Participants Market Presence (Intensity Map)

8. APEJ Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 8.1. Introduction
  • 8.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 8.2.1. China
    • 8.2.2. India
    • 8.2.3. Australia & NZ
    • 8.2.4. ASEAN
    • 8.2.5. Rest of APEJ
  • 8.3. Market Size (US$ Mn) Forecast By Country, 2024 - 2031
    • 8.3.1. China
    • 8.3.2. India
    • 8.3.3. Australia & NZ
    • 8.3.4. ASEAN
    • 8.3.5. Rest of APEJ
  • 8.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 8.4.1. Compressed Jet Nebulizer
      • 8.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 8.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 8.4.2. Ultrasound Nebulizer
    • 8.4.3. Mesh Nebulizer
  • 8.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 8.5.1. Compressed Jet Nebulizer
      • 8.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 8.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 8.5.2. Ultrasound Nebulizer
    • 8.5.3. Mesh Nebulizer
  • 8.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 8.6.1. COPD
    • 8.6.2. Cystic Fibrosis
    • 8.6.3. Asthma
    • 8.6.4. Others
  • 8.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 8.7.1. COPD
    • 8.7.2. Cystic Fibrosis
    • 8.7.3. Asthma
    • 8.7.4. Others
  • 8.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 8.8.1. Homecare Setting
    • 8.8.2. Out Patient Settings
    • 8.8.3. Others
      • 8.8.3.1. Hospitals
      • 8.8.3.2. Clinics
      • 8.8.3.3. Long Term Centers
  • 8.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 8.9.1. Homecare Setting
    • 8.9.2. Out Patient Settings
    • 8.9.3. Others
      • 8.9.3.1. Hospitals
      • 8.9.3.2. Clinics
      • 8.9.3.3. Long Term Centers
  • 8.10. Market Attractiveness Analysis
    • 8.10.1. By Country
    • 8.10.2. By Product Type
    • 8.10.3. By Application
    • 8.10.4. By End User
  • 8.11. Key Representative Market Participants
  • 8.12. Key Participants Market Presence (Intensity Map)

9. Japan Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 9.1. Introduction
  • 9.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 9.2.1. Compressed Jet Nebulizer
      • 9.2.1.1. Breath Actuated Pneumatic Nebulizer
      • 9.2.1.2. Vented Actuated Pneumatic Nebulizer
    • 9.2.2. Ultrasound Nebulizer
    • 9.2.3. Mesh Nebulizer
  • 9.3. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 9.3.1. Compressed Jet Nebulizer
      • 9.3.1.1. Breath Actuated Pneumatic Nebulizer
      • 9.3.1.2. Vented Actuated Pneumatic Nebulizer
    • 9.3.2. Ultrasound Nebulizer
    • 9.3.3. Mesh Nebulizer
  • 9.4. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 9.4.1. COPD
    • 9.4.2. Cystic Fibrosis
    • 9.4.3. Asthma
    • 9.4.4. Others
  • 9.5. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 9.5.1. COPD
    • 9.5.2. Cystic Fibrosis
    • 9.5.3. Asthma
    • 9.5.4. Others
  • 9.6. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 9.6.1. Homecare Setting
    • 9.6.2. Out Patient Settings
    • 9.6.3. Others
      • 9.6.3.1. Hospitals
      • 9.6.3.2. Clinics
      • 9.6.3.3. Long Term Centers
  • 9.7. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 9.7.1. Homecare Setting
    • 9.7.2. Out Patient Settings
    • 9.7.3. Others
      • 9.7.3.1. Hospitals
      • 9.7.3.2. Clinics
      • 9.7.3.3. Long Term Centers
  • 9.8. Market Attractiveness Analysis
    • 9.8.1. By Product Type
    • 9.8.2. By Application
    • 9.8.3. By End User
  • 9.9. Key Representative Market Participants
  • 9.10. Key Participants Market Presence (Intensity Map)

10. MEA Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 10.1.Introduction
  • 10.2. Historical Market Size (US$ Mn) Analysis By Country, 2019 - 2023
    • 10.2.1. GCC Countries
    • 10.2.2. South Africa
    • 10.2.3. Rest of MEA
  • 10.3. Market Size (US$ Mn) Forecast By Country, , 2024 - 2031
    • 10.3.1. GCC Countries
    • 10.3.2. South Africa
    • 10.3.3. Rest of MEA
  • 10.4. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 10.4.1. Compressed Jet Nebulizer
      • 10.4.1.1. Breath Actuated Pneumatic Nebulizer
      • 10.4.1.2. Vented Actuated Pneumatic Nebulizer
    • 10.4.2. Ultrasound Nebulizer
    • 10.4.3. Mesh Nebulizer
  • 10.5. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 10.5.1. Compressed Jet Nebulizer
      • 10.5.1.1. Breath Actuated Pneumatic Nebulizer
      • 10.5.1.2. Vented Actuated Pneumatic Nebulizer
    • 10.5.2. Ultrasound Nebulizer
    • 10.5.3. Mesh Nebulizer
  • 10.6. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 10.6.1. COPD
    • 10.6.2. Cystic Fibrosis
    • 10.6.3. Asthma
    • 10.6.4. Others
  • 10.7. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 10.7.1. COPD
    • 10.7.2. Cystic Fibrosis
    • 10.7.3. Asthma
    • 10.7.4. Others
  • 10.8. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 10.8.1. Homecare Setting
    • 10.8.2. Out Patient Settings
    • 10.8.3. Others
      • 10.8.3.1. Hospitals
      • 10.8.3.2. Clinics
      • 10.8.3.3. Long Term Centers
  • 10.9. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 10.9.1. Homecare Setting
    • 10.9.2. Out Patient Settings
    • 10.9.3. Others
      • 10.9.3.1. Hospitals
      • 10.9.3.2. Clinics
      • 10.9.3.3. Long Term Centers
  • 10.10. Market Attractiveness Analysis
    • 10.10.1. By Country
    • 10.10.2. By Product Type
    • 10.10.3. By Application
    • 10.10.4. By End User
  • 10.11. Key Representative Market Participants
  • 10.12. Key Participants Market Presence (Intensity Map)

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

  • 13.1. Competition Dashboard
  • 13.2. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.2.1. Agilent Technologies, Inc.
    • 13.2.2. Allied Healthcare Products, Inc.
    • 13.2.3. CareFusion Corporation (sub. Becton, Dickinson and Company)
    • 13.2.4. Covidien plc (sub. Medtronic)
    • 13.2.5. GE Healthcare
    • 13.2.6. GF Health Products Inc.
    • 13.2.7. Omron Healthcare, Inc.
    • 13.2.8. PARI GmbH
    • 13.2.9. Koninklijke Philips N.V.

14. Global Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Region

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Analysis By Region, 2019 - 2023
    • 14.2.1. North America
    • 14.2.2. Latin America
    • 14.2.3. Western Europe
    • 14.2.4. Eastern Europe
    • 14.2.5. APEJ
    • 14.2.6. Japan
    • 14.2.7. MEA
  • 14.3. Market Size (US$ Mn) Forecast By Region, 2024 - 2031
    • 14.3.1. North America
    • 14.3.2. Latin America
    • 14.3.3. Western Europe
    • 14.3.4. Eastern Europe
    • 14.3.5. APEJ
    • 14.3.6. Japan
    • 14.3.7. MEA
  • 14.4. Market Attractiveness Analysis By Region

15. Global Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Product Type

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2019 - 2023
    • 15.2.1. Compressed Jet Nebulizer
      • 15.2.1.1. Breath Actuated Pneumatic Nebulizer
      • 15.2.1.2. Vented Actuated Pneumatic Nebulizer
    • 15.2.2. Ultrasound Nebulizer
    • 15.2.3. Mesh Nebulizer
  • 15.3. Market Size (US$ Mn) Forecast By Product Type, 2024 - 2031
    • 15.3.1. Compressed Jet Nebulizer
      • 15.3.1.1. Breath Actuated Pneumatic Nebulizer
      • 15.3.1.2. Vented Actuated Pneumatic Nebulizer
    • 15.3.2. Ultrasound Nebulizer
    • 15.3.3. Mesh Nebulizer
  • 15.4. Market Attractiveness Analysis By Product Type

16. Global Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By Application

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Analysis By Application, 2019 - 2023
    • 16.2.1. COPD
    • 16.2.2. Cystic Fibrosis
    • 16.2.3. Asthma
    • 16.2.4. Others
  • 16.3. Market Size (US$ Mn) Forecast By Application, 2024 - 2031
    • 16.3.1. COPD
    • 16.3.2. Cystic Fibrosis
    • 16.3.3. Asthma
    • 16.3.4. Others
  • 16.4. Market Attractiveness Analysis By Application

17. Global Nebulizer Devices Market Analysis 2019 - 2023 and Forecast 2024 - 2031, By End User

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Analysis By End User, 2019 - 2023
    • 17.2.1. Homecare Setting
    • 17.2.2. Out Patient Settings
    • 17.2.3. Others
      • 17.2.3.1. Hospitals
      • 17.2.3.2. Clinics
      • 17.2.3.3. Long Term Centers
  • 17.3. Market Size (US$ Mn) Forecast By End User, 2024 - 2031
    • 17.3.1. Homecare Setting
    • 17.3.2. Out Patient Settings
    • 17.3.3. Others
      • 17.3.3.1. Hospitals
      • 17.3.3.2. Clinics
    • 17.3.4. Long Term Centers
  • 17.4. Market Attractiveness Analysis By End User

18. Global Market Analysis 2019 - 2023 and Forecast 2024 - 2031

  • 18.1.Market Size and Y-o-Y Growth
  • 18.2. Absolute $ Opportunity

19. Research Methodology

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦